Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

P Kardos, S Worsley, D Singh… - … journal of chronic …, 2016 - Taylor & Francis
Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …
被引用次数：31 相关文章

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.

P Kardos, S Worsley, D Singh… - … Journal of Chronic …, 2016 - europepmc.org
Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

P Kardos, S Worsley, D Singh… - International Journal of …, 2016 - go.gale.com
Long-acting muscarinic antagonist (LAMA) or long-acting [beta] 2-agonist (LABA)
bronchodilators and their combination are recommended for the maintenance treatment of …
[HTML] nih.gov

[HTML][HTML] Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

P Kardos, S Worsley, D Singh… - … Journal of Chronic …, 2016 - ncbi.nlm.nih.gov
Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

P Kardos, S Worsley, D Singh… - … Journal of Chronic …, 2016 - research.ed.ac.uk
Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

P Kardos, S Worsley, D Singh… - … journal of chronic …, 2016 - pubmed.ncbi.nlm.nih.gov
Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

P Kardos, S Worsley, D Singh… - … Journal of Chronic …, 2016 - dovepress.com
Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

P Kardos, S Worsley, D Singh… - International Journal of …, 2016 - docusalut.com
Long-acting muscarinic antagonist (LAMA) or long-acting beta2-agonist (LABA)
bronchodilators and their combination are recommended for the maintenance treatment of …

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

P Kardos, S Worsley, D Singh… - … journal of chronic …, 2016 - research.manchester.ac.uk
Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …